20 completed, 7 unknown, 5 terminated, 1 not yet recruiting. 35 Phase 2, 7 Phase 3, 3 Phase 1.
Follow Ceftriaxone: new trials by email Literature Review of Ceftriaxone trials Research Report on Ceftriaxone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours), Ceftriaxone for Injection, Amoxicillin - Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection | Phase 2 | Not yet recruiting | The University of Queensland | 300 | 2027-04-01 | 2026-03-20 |
| Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing Beta-lactam antibiotic (cefazolin, cefuroxime, cefotaxime, ceftazidime, ceftriaxone, cefepime, pre-pen, penicillin G, ampicillin, and histamine) double-blind skin testing, Culprit cephalosporin (cefazolin, ceftazidime, ceftriaxone, cefepime, cephalexin, cefaclor, cefadroxil, cefuroxime, cefpodoxime, cefdinir, or cefixime) double-blind placebo-controlled drug challenge, Similar cephalosporin (cefepime, ceftriaxone, cefaclor, cephalexin, cefixime, or cefdinir) antibiotic double-blind placebo-controlled drug challenge - Drug Allergy, Cephalosporin Allergy | Phase 2 | Recruiting | Massachusetts General Hospital | 300 | 2025-05-05 | 2026-11-12 |
| Piperacillin/Tazobactam Versus ceftriAxone and Metronidazole for Children With Perforated Appendicitis (ALPACA) Piperacillin/tazobactam, Normal saline, CefTRIAXone Injection - Appendicitis Perforated | Phase 2 | Completed | McMaster Children's Hospital | 16 | 2024-09-09 | 2026-07-07 |
| Prophylactic Antibiotic in Subtalar Fusion Surgery Ceftriaxone 2000 mg - Surgical Site Infection | Phase 2 / Phase 3 | Unknown | Assiut University | 102 | 2024-09-01 | 2024-07-30 |
| Comparison Between Effect of Empirical Antibiotic Prophylaxis Versus Enhanced Prophylactic Measures on Rate of Urinary Tract Infection After Flexible Ureteroscopy in Children With Pyuria Ceftriaxone (Rocephin®), Levofloxacin - Urinary Tract Infection (Diagnosis) | Phase 2 / Phase 3 | Completed | Ain Shams University | 140 | 2024-07-01 | 2025-11-17 |
| Antibiotic Instillation in Appendicitis Ceftriaxone, Intra-peritoneal Fluid Aspiration - Complicated Appendicitis, Acute Appendicitis | Phase 2 | Completed | Johns Hopkins All Children's Hospital | 190 | 2023-01-05 | 2025-03-13 |
| Tebipenem Trial in Children With Shigellosis Tebipenem Pivoxil, Azithromycin, Ceftriaxon - Shigellosis | Phase 2 | Completed | International Centre for Diarrhoeal Disease Research, Bangladesh | 132 | 2022-08-18 | 2026-09-01 |
| Propranolol on Post Stroke Immune Status and Infection Propranolol, Ceftriaxone - Stroke, Cerebrovascular Disorders | Phase 2 | Unknown | Tianjin Medical University General Hospital | 45 | 2022-06-01 | 2022-05-16 |
| Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae Cefixime, Ceftriaxone, Ciprofloxacin - Gonorrhea Male | Phase 2 | Completed | University of North Carolina, Chapel Hill | 65 | 2022-04-18 | 2026-03-02 |
| PROPER Trial of Pain and Inflammation After Knee Arthroscopy Ceftriaxone, Placebo - Meniscus Tear, Meniscus Lesion | Phase 2 | Terminated | Austin V Stone | 5 | 2021-12-28 | 2023-09-05 |
| Cefuroxime vs Ceftriaxone for SSI Prevention in Neurosurgery Cefuroxime (Zinnat®), Ceftriaxone (Rocephin®) - Surgical Site Infection, Antibiotics Prophylaxis | Phase 2 | Completed | Dr. Promise Tamunoipiriala Jaja | 96 | 2021-12-01 | 2023-05-26 |
| Ceftriaxone to PRevent pneumOnia and inflammatTion aftEr Cardiac arresT (PROTECT) Standard of care without prophylaxis, Antibiotic prophylaxis - Out-Of-Hospital Cardiac Arrest, Pneumonia | Phase 2 | Terminated | David J. Gagnon | 53 | 2021-08-20 | 2025-04-17 |
| Comparison of Efficacy of Two Combination Regimens for the Neisseria Gonorrhoeae and Chlamydia Coinfection Ceftriaxone 1000mg + doxycycline 100 mg, Cefixime 800mg + doxycycline 100 mg - Neisseria Gonorrhoeae Infection, Chlamydia Trachomatis Infection | Phase 2 | Completed | Haiphong University of Medicine and Pharmacy | 125 | 2021-07-15 | 2022-03-17 |
| Strategies to Reduce Mortality Among HIV-infected and HIV-exposed Children Admitted With Severe Acute Malnutrition Ceftriaxone Sodium, Ampicillin, Gentamicin - HIV-1-infection, Malnutrition, Child | Phase 2 / Phase 3 | Unknown | Makerere University | 300 | 2021-06-14 | 2021-09-30 |
| Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs Placenta-Derived MMSCs; Cryopreserved Placenta-Derived Multipotent Mesenchymal Stromal Cells, Antibiotics, Hormones - COVID-19 Pneumonia | Phase 1 / Phase 2 | Unknown | Institute of Cell Therapy | 30 | 2020-05-02 | 2020-07-08 |
| Combination Antibiotic Therapy Compared to Monotherapy in the Treatment of Acute COPD Beta-Lactams, Fluoroquinolone - COPD Exacerbation Acute | Phase 2 / Phase 3 | Completed | Haiphong University of Medicine and Pharmacy | 170 | 2020-01-01 | 2021-05-10 |
| Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis Ceftriaxone, Metronidazole, Placebo infusion - Ulcerative Colitis, Inflammatory Bowel Diseases | Phase 2 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 50 | 2019-04-01 | 2020-12-11 |
| To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementia Ceftriaxone, Placebo - Parkinson's Disease Dementia | Phase 2 | Completed | BrainX Corporation | 100 | 2019-02-15 | 2026-07-22 |
| Evaluation of an Antibiotic Regimen Pharmacokinetic Applicable to Enterococcus Faecalis Infective Endocarditis Ceftriaxone 4g/ 24h, Ceftriaxone 2g/ 12h - Infectious Endocarditis | Phase 2 | Completed | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 12 | 2018-04-23 | 2024-04-03 |
| Optimising Antibiotic Treatment for Sick Malnourished Children Ceftriaxone, Metronidazole - Malnutrition | Phase 2 | Unknown | University of Oxford | 81 | 2016-04-01 | 2017-07-02 |
Showing 20 of 35. Sign in to see all of them.
Infections (4) · Appendicitis (2) · Gonorrhea (2) · Pneumonia (2) · Pneumonia, Bacterial (2) · Surgical Wound Infection (2) · Anaphylaxis (1) · Bipolar Disorder (1) · Borrelia Infections (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Child Nutrition Disorders (1) · Cholangitis (1)
Haiphong University of Medicine and Pharmacy (2) · Ain Shams University (1) · Arrevus Inc. (1) · Assiut University (1) · Austin V Stone (1) · BrainX Corporation (1) · Cairo University (1) · David J. Gagnon (1) · Dr. Promise Tamunoipiriala Jaja (1) · Forest Laboratories (1) · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1) · Harold Wiesenfeld (1) · Hoffmann-La Roche (1) · Institute of Cell Therapy (1) · International Centre for Diarrhoeal Disease Research, Bangladesh (1)
United States (15) · Spain (4) · Bulgaria (3) · Canada (3) · Hungary (3) · Argentina (2) · Poland (2) · South Korea (2) · Ukraine (2) · Vietnam (2) · Australia (1) · Bangladesh (1) · Chile (1) · China (1) · Croatia (1)
Amos O Adeleye, FWACS, FACS (1) · Augustine A Adeolu, FWACS (1) · Austin V Stone, MD, PhD (1) · Brian A Fallon, MD (1) · Brian Fallon, M.D. (1) · David A Khan, MD (1) · David Gagnon, PharmD (1) · Harold C Wiesenfeld, MD (1)
PMID 25631195, PMID 26229155, PMID 27093162, PMID 27682068, PMID 28052855, PMID 30403954, PMID 32052831, PMID 33245002, PMID 35810277, PMID 35813373, PMID 38022210, PMID 38398427, PMID 40000088, PMID 40086037, PMID 40885534, PMID 41202087, PMID 42049314
2008 (1), P20GM139745 (1), U01AI162457 (1), U01AI184071 (1), U19AI084024 (1)